These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 33709190

  • 1. LINC00152 mediates CD8+ T-cell infiltration in gastric cancer through binding to EZH2 and regulating the CXCL9, 10/CXCR3 axis.
    Ou J, Lei P, Yang Z, Yang M, Luo L, Mo H, Luo G, He J.
    J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190
    [Abstract] [Full Text] [Related]

  • 2. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.
    Ohtani H, Jin Z, Takegawa S, Nakayama T, Yoshie O.
    J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207
    [Abstract] [Full Text] [Related]

  • 3. Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer.
    Chen WM, Huang MD, Sun DP, Kong R, Xu TP, Xia R, Zhang EB, Shu YQ.
    Oncotarget; 2016 Mar 01; 7(9):9773-87. PubMed ID: 26799422
    [Abstract] [Full Text] [Related]

  • 4. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
    Karin N.
    Front Immunol; 2020 Mar 01; 11():976. PubMed ID: 32547545
    [Abstract] [Full Text] [Related]

  • 5. miR-588 is a prognostic marker in gastric cancer.
    Chen Y, Zhang J, Gong W, Dai W, Xu X, Xu S.
    Aging (Albany NY); 2020 Dec 15; 13(2):2101-2117. PubMed ID: 33323542
    [Abstract] [Full Text] [Related]

  • 6. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
    Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ, Gimotty PA, Facciabene A, Jackson DG, Weber JS, Rodig SJ, Hodi SF, Kandalaft LE, Irving M, Zhang L, Foukas P, Rusakiewicz S, Delorenzi M, Coukos G.
    Cancer Cell; 2019 Jun 10; 35(6):885-900.e10. PubMed ID: 31185212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.
    Magnusen AF, Rani R, McKay MA, Hatton SL, Nyamajenjere TC, Magnusen DNA, Köhl J, Grabowski GA, Pandey MK.
    Int J Mol Sci; 2021 Nov 24; 22(23):. PubMed ID: 34884512
    [Abstract] [Full Text] [Related]

  • 10. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
    House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, Todd KL, Henderson MA, Giuffrida L, Petley EV, Sek K, Mardiana S, Gide TN, Quek C, Scolyer RA, Long GV, Wilmott JS, Loi S, Darcy PK, Beavis PA.
    Clin Cancer Res; 2020 Jan 15; 26(2):487-504. PubMed ID: 31636098
    [Abstract] [Full Text] [Related]

  • 11. Long Non-coding RNA LINC00152 Requires EZH2 to Promote Mesothelioma Cell Proliferation, Migration, and Invasion.
    Endo I, Amatya VJ, Kushitani K, Nakagiri T, Aoe K, Takeshima Y.
    Anticancer Res; 2023 Dec 15; 43(12):5367-5376. PubMed ID: 38030172
    [Abstract] [Full Text] [Related]

  • 12. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
    Wu X, Lahiri A, Haines GK, Flavell RA, Abraham C.
    J Immunol; 2014 Apr 01; 192(7):3409-18. PubMed ID: 24591373
    [Abstract] [Full Text] [Related]

  • 13. The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells.
    Nakajima S, Mimura K, Matsumoto T, Thar Min AK, Ito M, Nakano H, Neupane P, Kanke Y, Okayama H, Saito M, Momma T, Watanabe Y, Hanayama H, Hayase S, Saze Z, Kono K.
    Sci Rep; 2021 Aug 19; 11(1):16891. PubMed ID: 34413454
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.